Cargando…

Etanercept – A culprit agent in acute pancreatitis?

Drugs are responsible for 3%-5% of acute pancreatitis cases. There are a lot of medications that are known to cause acute pancreatitis, however only one case has been reported so far on Etanercept. This is a case about 62-year old female with history of Rheumatoid arthritis (RA) was started on Etane...

Descripción completa

Detalles Bibliográficos
Autores principales: Gunawan, Ferry, Fayyaz, Beenish, Mihardja, Tania Octaria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484468/
https://www.ncbi.nlm.nih.gov/pubmed/31044047
http://dx.doi.org/10.1080/20009666.2019.1593783
_version_ 1783414120224129024
author Gunawan, Ferry
Fayyaz, Beenish
Mihardja, Tania Octaria
author_facet Gunawan, Ferry
Fayyaz, Beenish
Mihardja, Tania Octaria
author_sort Gunawan, Ferry
collection PubMed
description Drugs are responsible for 3%-5% of acute pancreatitis cases. There are a lot of medications that are known to cause acute pancreatitis, however only one case has been reported so far on Etanercept. This is a case about 62-year old female with history of Rheumatoid arthritis (RA) was started on Etanercept to control her severe RA symptoms. Three weeks later, she presented with abdominal pain, nausea, vomiting and found to have acute pancreatitis based on clinical symptoms and elevated pancreatic enzymes. A thorough workup for the cause of pancreatitis was done and all were unrevealing. There was no history of alcohol use, abdominal trauma or any gastroenterology procedures. Ultrasound and CT abdomen ruled out hepatobiliary abnormalities. Lipid profile and electrolytes including calcium were also found to be normal. As all the workup was unremarkable, it was thought that drug-induced acute pancreatitis was likely the case. Etanercept was the only medication that was started recently, which made it the likely culprit and therefore it was stopped. Patient continued to improve and was discharged after medical stabilization. Her rheumatologist started her on Abatacept and she has remained symptom-free since then. Our case is interesting as it is the second case of etanercept induced acute pancreatitis. Furthermore, recent animal trials have demonstrated that etanercept potentially has a protective and/or therapeutic role in acute pancreatitis. However, no human studies regarding this topic have been performed. Due to limited data, a clear explanation behind these paradoxical actions of etanercept is still lacking.
format Online
Article
Text
id pubmed-6484468
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-64844682019-05-01 Etanercept – A culprit agent in acute pancreatitis? Gunawan, Ferry Fayyaz, Beenish Mihardja, Tania Octaria J Community Hosp Intern Med Perspect Case Report Drugs are responsible for 3%-5% of acute pancreatitis cases. There are a lot of medications that are known to cause acute pancreatitis, however only one case has been reported so far on Etanercept. This is a case about 62-year old female with history of Rheumatoid arthritis (RA) was started on Etanercept to control her severe RA symptoms. Three weeks later, she presented with abdominal pain, nausea, vomiting and found to have acute pancreatitis based on clinical symptoms and elevated pancreatic enzymes. A thorough workup for the cause of pancreatitis was done and all were unrevealing. There was no history of alcohol use, abdominal trauma or any gastroenterology procedures. Ultrasound and CT abdomen ruled out hepatobiliary abnormalities. Lipid profile and electrolytes including calcium were also found to be normal. As all the workup was unremarkable, it was thought that drug-induced acute pancreatitis was likely the case. Etanercept was the only medication that was started recently, which made it the likely culprit and therefore it was stopped. Patient continued to improve and was discharged after medical stabilization. Her rheumatologist started her on Abatacept and she has remained symptom-free since then. Our case is interesting as it is the second case of etanercept induced acute pancreatitis. Furthermore, recent animal trials have demonstrated that etanercept potentially has a protective and/or therapeutic role in acute pancreatitis. However, no human studies regarding this topic have been performed. Due to limited data, a clear explanation behind these paradoxical actions of etanercept is still lacking. Taylor & Francis 2019-04-12 /pmc/articles/PMC6484468/ /pubmed/31044047 http://dx.doi.org/10.1080/20009666.2019.1593783 Text en © 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group on behalf of Greater Baltimore Medical Center. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Gunawan, Ferry
Fayyaz, Beenish
Mihardja, Tania Octaria
Etanercept – A culprit agent in acute pancreatitis?
title Etanercept – A culprit agent in acute pancreatitis?
title_full Etanercept – A culprit agent in acute pancreatitis?
title_fullStr Etanercept – A culprit agent in acute pancreatitis?
title_full_unstemmed Etanercept – A culprit agent in acute pancreatitis?
title_short Etanercept – A culprit agent in acute pancreatitis?
title_sort etanercept – a culprit agent in acute pancreatitis?
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484468/
https://www.ncbi.nlm.nih.gov/pubmed/31044047
http://dx.doi.org/10.1080/20009666.2019.1593783
work_keys_str_mv AT gunawanferry etanerceptaculpritagentinacutepancreatitis
AT fayyazbeenish etanerceptaculpritagentinacutepancreatitis
AT mihardjataniaoctaria etanerceptaculpritagentinacutepancreatitis